CHANGE IN KDIGO KIDNEY RISK CATEGORY WITH SEMAGLUTIDE TREATMENT-A POST HOC ANALYSIS OF THE SUSTAIN 6 TRIAL

被引：0
|
作者：
Tuttle, Katherine [1 ]
Bain, Stephen C. [2 ]
Cherney, David [3 ]
Lawson, Jack [4 ]
Rasmussen, Soren [4 ]
Vrhnjak, Blaz [4 ]
Khunti, Kamlesh [5 ]
机构：
[1] Univ WA Providence Hlth, Spokane, WA 99258 USA
[2] Swansea Univ, Med Sch, Swansea, W Glam, Wales
[3] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[4] Novo Nordisk AS, Soborg, Denmark
[5] Univ Leicester, Leicester, Leics, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO462
引用
收藏
页码：I331 / I331
页数：1
相关论文
共 50 条
  • [21] Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
    Husain, Mansoor
    Bain, Stephen C.
    Holst, Anders Gaarsdal
    Mark, Thomas
    Rasmussen, Soren
    Lingvay, Ildiko
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [22] Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
    Mansoor Husain
    Stephen C. Bain
    Anders Gaarsdal Holst
    Thomas Mark
    Søren Rasmussen
    Ildiko Lingvay
    Cardiovascular Diabetology, 19
  • [23] Semaglutide reduced cardiovascular events regardless of metformin use: a post hoc exploratory subgroup analysis of SUSTAIN 6 and PIONEER
    Husain, M.
    Consoli, A.
    De Remigis, A.
    Meyer, A. S. P.
    Rasmussen, S.
    Bain, S.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 14 - 14
  • [24] DURATION OF DIABETES AND CARDIORENAL EFFICACY OF LIRAGLUTIDE AND SEMAGLUTIDE: A POST HOC ANALYSIS OF THE LEADER AND SUSTAIN-6 CLINICAL TRIALS
    Verma, Subodh
    Bain, Stephen C.
    Honore, Julie Broe
    Fries, Tea Monk
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Zinman, Bernard
    Buse, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1704 - 1704
  • [25] Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
    Peter Rossing
    Stephen C. Bain
    Heidrun Bosch-Traberg
    Ekaterina Sokareva
    Hiddo J. L. Heerspink
    Søren Rasmussen
    Linda G. Mellbin
    Cardiovascular Diabetology, 22
  • [26] Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo
    Tuttle, Katherine R.
    Bosch-Traberg, Heidrun
    Cherney, David Z. I.
    Hadjadj, Samy
    Lawson, Jack
    Mosenzon, Ofri
    Rasmussen, Soren
    Bain, Stephen C.
    KIDNEY INTERNATIONAL, 2023, 103 (04) : 772 - 781
  • [27] Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
    Rossing, Peter
    Bain, Stephen C.
    Bosch-Traberg, Heidrun
    Sokareva, Ekaterina
    Heerspink, Hiddo J. L.
    Rasmussen, Soren
    Mellbin, Linda G.
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [28] The effect of once-weekly semaglutide on MACE, blood pressure and lipids by race and ethnicity: a SUSTAIN 6 post hoc analysis
    Bain, S. C.
    Desouza, C. V.
    Gondolf, T.
    Hansen, T.
    Holst, I.
    Rea, R. R.
    Seufert, J.
    DIABETOLOGIA, 2019, 62 : S365 - S365
  • [29] SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE ON CARDIOVASCULAR OUTCOMES OVER TIME IN SUBJECTS WITH TYPE 2 DIABETES
    Bellary, S.
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. Gaarsdal
    Leiter, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 34 : E6 - E7
  • [30] Effect of once-weekly semaglutide on insulin use in subjects with type 2 diabetes: a post hoc analysis of SUSTAIN 6
    Seufert, J.
    Desouza, C.
    Kirk, A. R.
    Lawson, J.
    Lingvay, I.
    Sondergaard, A. L.
    Bain, S. C.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 251 - 252
12345